Canada: Alexion Pharmaceuticals V Canada FCA Dismisses Appeal Aimed At Constitutionality Of PMPRB Provisions

Last Updated: December 27 2017
Article by Andrew Shaughnessy, Yael Bienenstock, Teresa A. Reguly and Nic Wall

The Federal Court of Appeal's decision in Alexion Pharmaceuticals Inc. v. Canada (Attorney General), 2017 FCA 241 has significant implications for patentees before the Patented Medicine Prices Review Board (PMPRB) and for all litigants seeking judicial review of administrative decisions.

In the context of proceedings before the PMPRB, Alexion had brought an application for judicial review. It sought a declaration that the relevant sections of the Patent Act are ultra vires—or beyond the constitutional authority of—Parliament, because they are essentially a regulatory scheme over drug prices, and therefore improperly intrude into provincial jurisdiction over property and civil rights. The lower courts summarily dismissed Alexion's application, relying on previous decisions of the Court of Appeal that had determined that the relevant provisions are within Parliament's jurisdiction over patents. The Court of Appeal agreed with the lower courts. In addition to dismissing the appeal on its merits, the Court also held that, since the constitutionality of the relevant provisions had not been raised before the PMPRB at first instance, they were not properly before the Court on judicial review.

What You Need To Know

  • The Federal Court of Appeal's decision in Canada (Attorney General) v. Sandoz Canada Inc. remains binding authority for the proposition that the Patent Act's patented medicines drug pricing regime remains constitutional and binding on drug manufacturers.1
  • A party seeking judicial review of a federal administrative tribunal on jurisdictional or constitutional grounds should raise all arguments that the tribunal has the jurisdiction to hear. After the tribunal decides the issue, the party can then bring the application for judicial review in Federal Court.

Procedural Background

Sections 83 to 86 of the Patent Act provide the PMPRB with authority to make remedial orders where it concludes that a patentee is selling a drug at an excessive price. Various courts have previously considered the constitutionality of these provisions. In both Manitoba Society of Seniors Inc. v. Canada (Attorney General) and in Sandoz, manufacturers argued that the pricing provisions (in previous versions of the Patent Act) established a scheme of price regulation, and therefore both exceeded federal authority in relation to patents and intruded on provincial jurisdiction in relation to property and civil rights.2 In each case these arguments were rejected. The courts held that the provisions were in pith and substance related to patents and as such were valid federal legislation.

Alexion Pharmaceuticals Inc. was a party to a proceeding before the PMPRB relating to the price of its drug Soliris. It brought an application for judicial review in the Federal Court seeking a declaration that the relevant sections of the Patent Act are a pricing scheme that oversteps provincial authority over property and civil rights under the Constitution Act, 1867. The Attorney General brought a motion to dismiss the application on the basis that the Federal Court of Appeal's 2015 decision in Sandoz was binding authority and therefore the application had no chance of success. That motion was successful before the prothonotary and Alexion's appeal to the Federal Court was dismissed.

The Decision

The Federal Court of Appeal dismissed Alexion's appeal in Alexion Pharmaceuticals Inc. v. Canada (Attorney General), 2017 FCA 241. Writing for the Court, Justice Laskin held that Sandoz was binding authority on the constitutionality of the relevant provisions of the Patent Act. Although Alexion attempted to distinguish Sandoz on a variety of grounds—including that Sandoz had not squarely addressed the constitutionality of these provisions and that this case had a fuller factual record on which to determine the issue—these arguments were rejected.

In addition, although neither the Attorney General nor the courts below raised this issue, the Court of Appeal dismissed the appeal on the sole ground that Alexion had failed to abide by the "normal rule" that "parties to an administrative proceeding may proceed to the court system only after all adequate remedial recourses in the administrative process have been exhausted."3 The Court emphasized that the rule exists in the interests of justice (for example, to avoid multiplicity of proceedings and to give the Court the perspective of the administrative decision-maker) and that the Court itself is entitled to raise it on its own motion. In this case, since Alexion had failed to raise the constitutionality of the provisions before the PMPRB, it was not entitled to raise them on a judicial review application.

Is the Door Closed on the Constitutionality of the PMPRB?

Although the issue has been before the courts a number of times, Alexion may not be the final word. While Justice Laskin decided that Sandoz was binding, he noted several arguments that might have been available to Alexion. These include whether the Court should depart from the Sandoz decision, or whether the Court should exercise its discretion to permit Alexion to develop a record for possible consideration by the Supreme Court of Canada. Additional grounds may also become available with the amendments to the PMPRB's regulations, which are scheduled to come into force January 1, 2019.


1 2015 FCA 249 (Sandoz).

2 Constitution Act, 1867, sections 91(22) and 92(13); (1991), 77 D.L.R. (4th) 48535 C.P.R. (3d) 66 (Man. Q.B.), affirmed (1992), 96 D.L.R. (4th) 606, 45 C.P.R. (3d) 194 (Man. C.A.).

3 Alexion at para. 47

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on

Click to Login as an existing user or Register so you can print this article.

Similar Articles
Relevancy Powered by MondaqAI
In association with
Related Topics
Similar Articles
Relevancy Powered by MondaqAI
Related Articles
Related Video
Up-coming Events Search
Font Size:
Mondaq on Twitter
Mondaq Free Registration
Gain access to Mondaq global archive of over 375,000 articles covering 200 countries with a personalised News Alert and automatic login on this device.
Mondaq News Alert (some suggested topics and region)
Select Topics
Registration (please scroll down to set your data preferences)

Mondaq Ltd requires you to register and provide information that personally identifies you, including your content preferences, for three primary purposes (full details of Mondaq’s use of your personal data can be found in our Privacy and Cookies Notice):

  • To allow you to personalize the Mondaq websites you are visiting to show content ("Content") relevant to your interests.
  • To enable features such as password reminder, news alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our content providers ("Contributors") who contribute Content for free for your use.

Mondaq hopes that our registered users will support us in maintaining our free to view business model by consenting to our use of your personal data as described below.

Mondaq has a "free to view" business model. Our services are paid for by Contributors in exchange for Mondaq providing them with access to information about who accesses their content. Once personal data is transferred to our Contributors they become a data controller of this personal data. They use it to measure the response that their articles are receiving, as a form of market research. They may also use it to provide Mondaq users with information about their products and services.

Details of each Contributor to which your personal data will be transferred is clearly stated within the Content that you access. For full details of how this Contributor will use your personal data, you should review the Contributor’s own Privacy Notice.

Please indicate your preference below:

Yes, I am happy to support Mondaq in maintaining its free to view business model by agreeing to allow Mondaq to share my personal data with Contributors whose Content I access
No, I do not want Mondaq to share my personal data with Contributors

Also please let us know whether you are happy to receive communications promoting products and services offered by Mondaq:

Yes, I am happy to received promotional communications from Mondaq
No, please do not send me promotional communications from Mondaq
Terms & Conditions (the Website) is owned and managed by Mondaq Ltd (Mondaq). Mondaq grants you a non-exclusive, revocable licence to access the Website and associated services, such as the Mondaq News Alerts (Services), subject to and in consideration of your compliance with the following terms and conditions of use (Terms). Your use of the Website and/or Services constitutes your agreement to the Terms. Mondaq may terminate your use of the Website and Services if you are in breach of these Terms or if Mondaq decides to terminate the licence granted hereunder for any reason whatsoever.

Use of

To Use you must be: eighteen (18) years old or over; legally capable of entering into binding contracts; and not in any way prohibited by the applicable law to enter into these Terms in the jurisdiction which you are currently located.

You may use the Website as an unregistered user, however, you are required to register as a user if you wish to read the full text of the Content or to receive the Services.

You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these Terms or with the prior written consent of Mondaq. You may not use electronic or other means to extract details or information from the Content. Nor shall you extract information about users or Contributors in order to offer them any services or products.

In your use of the Website and/or Services you shall: comply with all applicable laws, regulations, directives and legislations which apply to your Use of the Website and/or Services in whatever country you are physically located including without limitation any and all consumer law, export control laws and regulations; provide to us true, correct and accurate information and promptly inform us in the event that any information that you have provided to us changes or becomes inaccurate; notify Mondaq immediately of any circumstances where you have reason to believe that any Intellectual Property Rights or any other rights of any third party may have been infringed; co-operate with reasonable security or other checks or requests for information made by Mondaq from time to time; and at all times be fully liable for the breach of any of these Terms by a third party using your login details to access the Website and/or Services

however, you shall not: do anything likely to impair, interfere with or damage or cause harm or distress to any persons, or the network; do anything that will infringe any Intellectual Property Rights or other rights of Mondaq or any third party; or use the Website, Services and/or Content otherwise than in accordance with these Terms; use any trade marks or service marks of Mondaq or the Contributors, or do anything which may be seen to take unfair advantage of the reputation and goodwill of Mondaq or the Contributors, or the Website, Services and/or Content.

Mondaq reserves the right, in its sole discretion, to take any action that it deems necessary and appropriate in the event it considers that there is a breach or threatened breach of the Terms.

Mondaq’s Rights and Obligations

Unless otherwise expressly set out to the contrary, nothing in these Terms shall serve to transfer from Mondaq to you, any Intellectual Property Rights owned by and/or licensed to Mondaq and all rights, title and interest in and to such Intellectual Property Rights will remain exclusively with Mondaq and/or its licensors.

Mondaq shall use its reasonable endeavours to make the Website and Services available to you at all times, but we cannot guarantee an uninterrupted and fault free service.

Mondaq reserves the right to make changes to the services and/or the Website or part thereof, from time to time, and we may add, remove, modify and/or vary any elements of features and functionalities of the Website or the services.

Mondaq also reserves the right from time to time to monitor your Use of the Website and/or services.


The Content is general information only. It is not intended to constitute legal advice or seek to be the complete and comprehensive statement of the law, nor is it intended to address your specific requirements or provide advice on which reliance should be placed. Mondaq and/or its Contributors and other suppliers make no representations about the suitability of the information contained in the Content for any purpose. All Content provided "as is" without warranty of any kind. Mondaq and/or its Contributors and other suppliers hereby exclude and disclaim all representations, warranties or guarantees with regard to the Content, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. To the maximum extent permitted by law, Mondaq expressly excludes all representations, warranties, obligations, and liabilities arising out of or in connection with all Content. In no event shall Mondaq and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use of the Content or performance of Mondaq’s Services.


Mondaq may alter or amend these Terms by amending them on the Website. By continuing to Use the Services and/or the Website after such amendment, you will be deemed to have accepted any amendment to these Terms.

These Terms shall be governed by and construed in accordance with the laws of England and Wales and you irrevocably submit to the exclusive jurisdiction of the courts of England and Wales to settle any dispute which may arise out of or in connection with these Terms. If you live outside the United Kingdom, English law shall apply only to the extent that English law shall not deprive you of any legal protection accorded in accordance with the law of the place where you are habitually resident ("Local Law"). In the event English law deprives you of any legal protection which is accorded to you under Local Law, then these terms shall be governed by Local Law and any dispute or claim arising out of or in connection with these Terms shall be subject to the non-exclusive jurisdiction of the courts where you are habitually resident.

You may print and keep a copy of these Terms, which form the entire agreement between you and Mondaq and supersede any other communications or advertising in respect of the Service and/or the Website.

No delay in exercising or non-exercise by you and/or Mondaq of any of its rights under or in connection with these Terms shall operate as a waiver or release of each of your or Mondaq’s right. Rather, any such waiver or release must be specifically granted in writing signed by the party granting it.

If any part of these Terms is held unenforceable, that part shall be enforced to the maximum extent permissible so as to give effect to the intent of the parties, and the Terms shall continue in full force and effect.

Mondaq shall not incur any liability to you on account of any loss or damage resulting from any delay or failure to perform all or any part of these Terms if such delay or failure is caused, in whole or in part, by events, occurrences, or causes beyond the control of Mondaq. Such events, occurrences or causes will include, without limitation, acts of God, strikes, lockouts, server and network failure, riots, acts of war, earthquakes, fire and explosions.

By clicking Register you state you have read and agree to our Terms and Conditions